Assessment Services
Drug & Device Development Service
The MCHRI Drug & Device Development Service was established to provide direct assistance to investigators in every stage of medical product development. Ensuring the project is on track, is targeting a robust market, and inclusive of all elements for regulatory approval are critical fundamentals which serve to expedite the translation of a health technology into the clinical setting.
Typical assessment services include:
Project management
- Roadmap creation & timeline development
- Project budgeting & cost tracking
- Centralized point of contact
Regulatory strategy development
- Target Product Profile creation
- Pre-clinical development planning
- Identification of pathways from bench to bedside
Market analysis & assessment
- Clinical need assessment
- Market sizing
- Competition & trend analysis
Contact
Grant Wells, MS
Director of Innovation & Development
gwells2@stanford.edu